News

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
High-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...
The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...
More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...
More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and ...
Get your weekly dose of the top news that matters in our newsletter.